Cancer Research  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ilsley, J. N.M.
Right arrow Articles by Rosenberg, D. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ilsley, J. N.M.
Right arrow Articles by Rosenberg, D. W.
[Cancer Research 65, 2636-2643, April 1, 2005]
© 2005 American Association for Cancer Research


Molecular Biology, Pathobiology, and Genetics

Cytoplasmic Phospholipase A2 Deletion Enhances Colon Tumorigenesis

Jillian N.M. Ilsley1, Masako Nakanishi1, Christopher Flynn1, Glenn S. Belinsky1, Sylvain De Guise2, John N. Adib3, Rick T. Dobrowsky3, Joseph V. Bonventre4 and Daniel W. Rosenberg1

1 Program in Colorectal Cancer, Center for Molecular Medicine, University of Connecticut Health Center, Farmington, Connecticut; 2 Department of Pathobiology and Veterinary Science, University of Connecticut, Storrs, Connecticut; 3 Department of Pharmacology and Toxicology, University of Kansas, Lawrence, Kansas; and 4 Renal Division, Brigham and Women's Hospital, Department of Medicine, Harvard School of Medicine, Harvard-Massachusetts Institute of Technology Division of Health Sciences and Technology, Boston, Massachusetts

Requests for reprints: Daniel W. Rosenberg, Program in Colorectal Cancer, Center for Molecular Medicine, University of Connecticut Health Center, 263 Farmington Avenue, Farmington, CT 06030. Phone: 860-679-8704; Fax: 860-679-7639; E-mail: rosenberg{at}nso2.uchc.edu.

Cellular pools of free arachidonic acid are tightly controlled through enzymatic release of the fatty acid and subsequent utilization by downstream enzymes including the cyclooxygenases. Arachidonic acid cleavage from membrane phospholipids is accomplished by the actions of phospholipase A2 (PLA2). Upon release, free arachidonic acid provides substrate for the synthesis of eicosanoids. However, under certain conditions, arachidonic acid may participate in ceramide-mediated apoptosis. Disruption of arachidonic acid homeostasis can shift the balance of cell turnover in favor of tumorigenesis, via overproduction of tumor-promoting eicosanoids or alternatively by limiting proapoptotic signals. In the following study, we evaluated the influence of genetic deletion of a key intracellular phospholipase, cytoplasmic PLA2 (cPLA2), on azoxymethane-induced colon tumorigenesis. Heterozygous and null mice, upon treatment with the organotropic colon carcinogen, azoxymethane, developed a significant (P < 0.05) increase in colon tumor multiplicity (7.2-fold and 5.5-fold, respectively) relative to their wild-type littermates. This enhanced tumor sensitivity may be explained, in part, by the attenuated levels of apoptosis observed by terminal deoxynucleotidyl transferase–mediated nick end labeling staining within the colonic epithelium of heterozygous and null mice ({approx}50% of wild type). The lower frequency of apoptotic cells corresponded with reduced ceramide levels (69% and 46% of wild-type littermates, respectively). Remarkably, increased tumorigenesis resulting from cPLA2 deletion occurred despite a significant reduction in prostaglandin E2 production, even in cyclooxygenase-2–overexpressing tumors. These data contribute new information that supports a fundamental role of cPLA2 in the control of arachidonic acid homeostasis and cell turnover. Our findings indicate that the proapoptotic role of cPLA2 in the colon may supercede its contribution to eicosanoid production in tumor development.

Key Words: cPLA2 • colon • apoptosis • arachidonic acid • ceramide




This article has been cited by other articles:


Home page
Cancer Res.Home page
M. Nakanishi, D. C. Montrose, P. Clark, P. R. Nambiar, G. S. Belinsky, K. P. Claffey, D. Xu, and D. W. Rosenberg
Genetic Deletion of mPGES-1 Suppresses Intestinal Tumorigenesis
Cancer Res., May 1, 2008; 68(9): 3251 - 3259.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. C. Maia, C. A. Culver, and S. M. Laster
Evidence against Calcium as a Mediator of Mitochondrial Dysfunction during Apoptosis Induced by Arachidonic Acid and Other Free Fatty Acids
J. Immunol., November 1, 2006; 177(9): 6398 - 6404.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M.A. Hull, O.O. Faluyi, C.W.S. Ko, S. Holwell, D.J. Scott, R.J. Cuthbert, R. Poulsom, R. Goodlad, C. Bonifer, A.F. Markham, et al.
Regulation of stromal cell cyclooxygenase-2 in the ApcMin/+ mouse model of intestinal tumorigenesis
Carcinogenesis, March 1, 2006; 27(3): 382 - 391.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2005 by the American Association for Cancer Research.